The Del20q Myelodysplastic Syndrome (MDS) Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting deletions in the long arm of chromosome 20. This particular genetic anomaly is associated with various forms of myelodysplastic syndromes, a group of disorders caused by poorly formed or dysfunctional blood cells. The test plays a crucial role in the diagnosis and management of MDS, helping healthcare providers to tailor treatment strategies based on the genetic profile of the disorder.
Performed in the state-of-the-art facilities of DNA Labs UAE, the test involves a detailed analysis of the patient's genetic material, using advanced techniques to identify the presence of the 20q deletion. This precise approach ensures high accuracy and reliability in the results, aiding in the early detection and intervention of MDS.
The cost of the Del20q MDS Test at DNA Labs UAE is set at 1200 AED. This investment covers the comprehensive services provided by the lab, including the collection of samples, genetic analysis, and the provision of a detailed report by their team of expert geneticists. Patients and healthcare providers can expect a seamless and informative experience, contributing to the effective management of Myelodysplastic Syndromes.
Fragile X Tremor Ataxia Syndrome (FXTAS) is a genetic condition that primarily affects the nervous system, leading to symptoms such as tremors, problems with balance and coordination (ataxia), and cognitive impairments. FXTAS is linked to the FMR1 gene, which can carry a premutation causing the syndrome. Individuals, especially older adults, carrying this premutation may develop FXTAS, although not everyone with the premutation will be affected.
To diagnose FXTAS, a specific genetic test is conducted to identify the FMR1 premutation. In the UAE, this test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The test is crucial for individuals who have a family history of FXTAS or exhibit symptoms related to the syndrome. It involves collecting a DNA sample, typically through a blood draw, and analyzing it for the presence of the FMR1 premutation.
The cost of the FXTAS test at DNA Labs UAE is 1290 AED. This investment allows individuals and families to gain crucial information regarding their genetic health, potentially guiding medical treatment and management decisions. It's also a step forward in understanding the risk for future generations, as the FMR1 premutation can be passed down to offspring.
The Heavy Metal Screen Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect the presence and concentration of various heavy metals in the body. This test is crucial for individuals who may have been exposed to environments with high levels of toxic metals, such as lead, mercury, cadmium, arsenic, and others, which can have detrimental effects on health. With a cost of 1290 AED, the test provides valuable insights into potential heavy metal poisoning or accumulation, enabling healthcare providers to devise appropriate treatment or preventive measures. Conducted with precision and care, the Heavy Metal Screen Test at DNA Labs UAE is a vital resource for ensuring personal health and safety in the face of environmental pollutants.
The Kidney Stone Formation Diagnostic Panel Test is a comprehensive analysis designed to identify the underlying causes and risk factors associated with kidney stone formation. Offered at DNA Labs UAE, this panel utilizes advanced diagnostic techniques to evaluate various biochemical markers and genetic predispositions that may contribute to the development of kidney stones. With a cost of 1290 AED, the test aims to provide patients with a detailed understanding of their specific risk factors, enabling personalized prevention strategies and targeted treatments to mitigate the recurrence of kidney stones. By analyzing factors such as calcium levels, oxalate levels, uric acid, and other relevant parameters, the test offers valuable insights into the patient's metabolic profile and potential genetic vulnerabilities. This diagnostic tool is crucial for individuals with a history of kidney stones or those at increased risk, facilitating early intervention and improved management of their condition.
The Lead Poisoning Panel Test is a crucial diagnostic tool used to assess the levels of lead in the blood. This test is particularly important for individuals who are at risk of lead exposure due to their environment or occupation. Lead poisoning can lead to a variety of health issues, ranging from cognitive impairments and developmental delays in children to kidney damage and high blood pressure in adults. Early detection through this panel test is key to preventing long-term damage and initiating appropriate treatment.
At DNA Labs UAE, the Lead Poisoning Panel Test is available for 1290 AED. The test is conducted with precision and care, ensuring accurate results that can guide medical interventions. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the reliability of the test results. Upon completion of the test, individuals receive a comprehensive report that outlines their blood lead levels, offering critical insights into their exposure and potential health risks. This information is invaluable for both patients and healthcare providers in managing and mitigating the effects of lead poisoning.
Leber's Hereditary Optic Neuropathy (LHON) Mitochondrial Mutation Detection Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying specific mitochondrial DNA mutations associated with LHON. This genetic condition primarily affects the optic nerves, leading to a sudden or gradual loss of central vision in one or both eyes, predominantly in young adults. The test, priced at 1290 AED, involves analyzing the patient's DNA to detect the presence of common mutations in the mitochondrial genes that are known to cause LHON. These mutations disrupt the normal function of the mitochondria, affecting the optic nerve and leading to vision loss. Early detection through this test can be crucial for affected individuals and their families to understand the genetic basis of the condition, explore potential treatments, and make informed decisions about managing the disease. DNA Labs UAE provides this testing service with a focus on accuracy, confidentiality, and support for patients and their families navigating the implications of LHON.
Leigh Syndrome Mitochondrial Mutation Detection Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify genetic mutations associated with Leigh Syndrome, a severe neurological disorder. This test specifically targets the mitochondrial DNA to find any abnormalities that could indicate the presence of this condition, which often leads to progressive loss of mental and movement abilities. The process involves a detailed analysis of the patient's DNA sample, employing advanced genetic sequencing technologies to ensure accurate detection of mutations. The cost of the test is set at 1290 AED, making it accessible for individuals seeking comprehensive insights into their genetic health, particularly for families with a history of Leigh Syndrome or related mitochondrial disorders. By pinpointing the exact genetic mutation, this test plays a crucial role in early diagnosis, allowing for timely intervention and management of the syndrome.
Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC), also known as Van der Knaap disease, is a rare genetic disorder characterized by an abnormally large brain (megalencephaly) along with white matter abnormalities and the formation of cysts in the subcortical area of the brain. This condition leads to a variety of neurological symptoms, including motor function decline, epilepsy, and ataxia. The disease primarily affects children and is caused by mutations in the MLC1 or HEPACAM genes.
To accurately diagnose this condition, the Van Der Knaap and Nalband MLC Gene Hotspot Mutation Test is utilized. This genetic test specifically targets the hotspot mutations within the MLC1 and HEPACAM genes that are commonly associated with the disease. The test is a crucial tool for confirming the diagnosis of MLC, enabling targeted management and therapy for affected individuals.
DNA Labs UAE offers this specialized genetic testing service. The test cost is set at 1290 AED, providing an accessible option for families seeking answers about this rare condition. By identifying the specific mutations causing MLC, this test facilitates a better understanding of the disease's progression and potential interventions.
The Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) Mutation Detection Test is a specialized diagnostic examination offered at DNA Labs UAE. Priced at 1290 AED, this test is crucial for identifying the genetic mutations associated with MELAS, a rare mitochondrial disorder. MELAS is characterized by a spectrum of symptoms including muscle weakness and pain, recurrent headaches, loss of appetite, vomiting, and stroke-like episodes that can lead to seizures, vision loss, and cognitive impairment. Early and accurate detection through the MELAS Mutation Detection Test allows for appropriate management strategies to be implemented, potentially mitigating the progression of symptoms and improving the quality of life for affected individuals. The test involves analyzing the patient's DNA to identify mutations in mitochondrial genes that are known to cause MELAS, providing a vital tool for diagnosis and family planning advice. Conducted at DNA Labs UAE, this test represents an important step forward in the management of mitochondrial diseases within the region.
The MuSK (Muscle Specific Kinase) Antibody Test is a specialized diagnostic tool used to detect the presence of antibodies against MuSK in the blood. MuSK is a protein essential for the formation and maintenance of the neuromuscular junction, where nerve cells meet muscle cells to control muscle activity. Antibodies against MuSK can disrupt this connection, leading to muscle weakness and fatigue, and are often associated with Myasthenia Gravis (MG), a chronic autoimmune neuromuscular disorder.
The test is particularly crucial for diagnosing MG cases that do not have antibodies against the acetylcholine receptor (AChR), making it an invaluable tool for identifying seronegative Myasthenia Gravis (SNMG). Positive results can help guide treatment decisions, including immunosuppressive therapies that can significantly improve patient outcomes.
At DNA Labs UAE, the MuSK Muscle Specific Kinase Antibody Test is offered at a cost of 1290 AED. The facility ensures accurate and reliable testing, utilizing advanced diagnostic technologies and methodologies to provide timely results. This test is essential for healthcare professionals in diagnosing and managing conditions associated with MuSK antibodies, offering a pathway to better patient care and treatment strategies.
